Its about using a known anti-inflammatory effect of these drugs at the lowest dose that meaningfully improves disease control
After administration of Triple GLP-1/GIP/glucagon receptor agonist, learning and memory impairment of AD models (APP/PS1 mice and 3Tg-AD mice) was improved, amyloid plaques, tau pathology, inflammation response and oxidative stress in brains of two AD models were ameliorated (239241)
Improved confidence and self-esteem Weight loss and improved metabolic health can enhance body confidence, mobility, and self-efficacy
Supportive follow-up care
These advances again produce better long-term glycemic control and stable metabolic results, reinforcing their clinical value
New iterations have been rolling out ever since